Chemical shift mapping of shikimate-3-phosphate binding to the isolated N-terminal domain of 5-enolpyruvylshikimate-3-phosphate synthase  by Stauffer, Melissa E. et al.
Chemical shift mapping of shikimate-3-phosphate binding to the isolated
N-terminal domain of 5-enolpyruvylshikimate-3-phosphate synthase
Melissa E. Stau¡era;1, John K. Younga;1, Gregory L. Helmsb, Jeremy N.S. Evansa;b;*
aSchool of Molecular Biosciences, Washington State University, Pullman, WA 99164-4660, USA
bCenter for NMR Spectroscopy, Washington State University, Pullman, WA 99164-4660, USA
Received 9 April 2001; revised 9 May 2001; accepted 10 May 2001
First published online 1 June 2001
Edited by Thomas L. James
Abstract To facilitate evaluation of enzyme^ligand complexes
in solution, we have isolated the 26-kDa N-terminal domain of 5-
enolpyruvylshikimate-3-phosphate (EPSP) synthase for analysis
by NMR spectroscopy. The isolated domain is capable of binding
the substrate shikimate-3-phosphate (S3P), and this letter
reports the localization of the S3P binding site using chemical
shift mapping. Based on the NMR data, we propose that Ser23,
Arg27, Ser197, and Tyr200 are directly involved in S3P binding.
We also describe changes in the observed nuclear Overhauser
effects (NOEs) that are consistent with a partial conformational
change in the N-terminal domain upon S3P binding. ß 2001
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
5-Enolpyruvylshikimate-3-phosphate (EPSP) synthase (EC
2.5.1.19) catalyzes the formation of EPSP (Fig. 1) from shiki-
mate-3-phosphate (S3P) and phosphoenolpyruvate, a key step
in the aromatic amino acid biosynthetic pathway of plants
and bacteria. The enzyme is a promising target for antimicro-
bial [1], antiparasitic [2] and herbicide [3] development, since
the pathway in which it occurs is absent from mammals.
EPSP synthase is also the site of action of glyphosate
(GLP), the active ingredient of the well-known herbicides
RoundUp1 [4] and Touchdown1, and as such represents a
model system for rational inhibitor design.
The crystal structure of unliganded EPSP synthase has been
determined at 3.0 Aî resolution by Stallings et al. [5]. It reveals
a bilobal globular protein structure whose domains consist of
repeated folding motifs ordered in a near-symmetric fashion
(Fig. 1). The domains maintain an open conformation in the
absence of substrates, but catalysis requires a conformational
change to a closed state, and the particular substrate interac-
tions that trigger this event are in question due to the presence
of contradictory crystal structures in the literature. In 1997,
Stallings et al. released several pictures of their enzymeWS3P
complex [6], in which the enzyme maintains an open confor-
mation, and all contacts between S3P and the enzyme are in
the N-terminal domain. More recently, Scho«nbrunn et al. [7]
have crystallized the binary enzymebS3P complex in a closed
conformation where S3P has multiple contacts with residues
in both domains. Both structures have experimental caveats.
The Stallings structure crystals were obtained by soaking pre-
formed unliganded enzyme crystals in a solution of S3P,
which may have biased the structure toward an open confor-
mation. The Scho«nbrunn structure, on the other hand, was
crystallized in the presence of formate and phosphate ions,
which mimic the functional groups of GLP and may have
induced the conformational change to the closed state. The
con£ict between these two structures can be resolved by ex-
amination of the liganded structure(s) of the enzyme in solu-
tion.
NMR spectroscopy has a unique ability to de¢ne the li-
ganded solution state structure(s) of EPSP synthase with re-
spect to the relative dynamics of the two domains and their
subdomains, as well as the timescale of conformational
changes that occur during the catalytic cycle. To facilitate
analysis by NMR, we have prepared separate constructs en-
coding each of the two domains of EPSP synthase. Following
NMR assignment of the 26-kDa N-terminal domain [8] and
the discovery and characterization of its binding to S3P [9], we
proceeded to obtain NMR assignments of the S3P-bound N-
terminal domain. Here we report chemical shift changes that
occur within the N-terminal domain upon S3P binding and
map them to a proposed binding site based on their local-
ization. We also describe some di¡erences in the nuclear Over-
hauser e¡ect (NOE) patterns of the free and bound domains
that are consistent with a partial conformational change upon
S3P binding. Because domain closure is not a possibility for
this construct, the conformational changes due to S3P binding
can be di¡erentiated from those caused by (or resulting from)
domain closure, which may ultimately aid the design of spe-
ci¢c inhibitors of domain closure.
2. Materials and methods
2.1. Sample preparation
The N-terminal domain of EPSP synthase was produced [9] and
NMR samples prepared [8] as described previously. Samples typically
consisted of V1 mM protein in 50 mM Tris, pH 7.8, 3 mM NaN3,
1 mM DTT. In samples containing substrate, S3P was added from a
concentrated stock to a ¢nal molar ratio of 1.5:1 (S3P:protein). S3P
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binding was con¢rmed by observing the peak positions in the 15N-
heteronuclear single quantum coherence (HSQC) spectrum.
2.2. NMR spectroscopy
Sequential assignments and secondary structure prediction of the
S3P-bound N-terminal domain were obtained as described for the
domain alone [8]. The chemical shift list has been deposited in the
BioMagResBank (http://www.bmrb.wisc.edu) under accession num-
ber 4848. NMR experiments were carried out at 22‡C on a Varian
Inova 500 NMR spectrometer (499.86 MHz, 1H). The necessary cor-
relation experiments were provided with Varian’s Protein Pack soft-
ware. Sequential backbone assignments of 1HN and 15N nuclei were
used to determine the extent of chemical shift changes upon S3P
binding.
3. Results
3.1. Chemical shift mapping
From the individual assignments for the N-terminal domain
alone and in the presence of S3P, we were able to extract a set
of residues whose 1H and 15N chemical shifts changed the
most upon S3P binding. This type of chemical shift mapping
is often used to describe protein^protein and protein^ligand
Fig. 1. Ribbon diagram of EPSP synthase showing how the protein was segmented into its constituent domains (PDB ¢le 1EPS). ‘N’ and ‘C’
indicate the N-terminal and C-terminal domains, respectively. The reaction catalyzed by EPSP synthase is also shown, along with the structure
of the inhibitor GLP.
C
Fig. 2. A: Two-dimensional plot of the 1HN and 15N chemical shift
di¡erences between the N-terminal domain alone and in the pres-
ence of S3P. The elliptical cuto¡ was de¢ned as þ 1 ppm for 15N
and þ 0.35 ppm for 1HN. Residues lying outside this cuto¡ were de-
termined to be signi¢cantly shifted by S3P binding. B: Ribbon dia-
gram of the N-terminal domain looking down the intersubdomain
axis. Each subdomain is numbered according to Stallings et al. [5]
and can be distinguished by its pair of helices. Residues in black ex-
perience signi¢cant changes in chemical shift upon S3P binding.
Proposed S3P binding residues are rendered in CPK and are la-
beled. The charcoal segments in subdomain 4 undergo changes in
their NOE patterns upon binding as described in the text.
FEBS 24971 12-6-01
M.E. Stau¡er et al./FEBS Letters 499 (2001) 182^186 183
interactions (see, for example, [10,11]), where an interface or
binding region is proposed based on changes in chemical shift
between the free and interacting species. The changes in 1H
and 15N for each residue were plotted in two dimensions, and
an elliptical cuto¡ was used (as in [12]) to determine which
residues were signi¢cantly shifted. These residues are labeled
in Fig. 2A, and their positions in the sequence are highlighted
in Fig. 4. With the exception of four residues in subdomain 3
close to the hinge region between N- and C-terminal domains,
all of the residues are located in subdomain 5 (nomenclature
from Stallings et al. [5]). Residues 165, 168, and 192^197 are
located in loop regions between the L-sheet and K-helix seg-
ments of this subdomain. Some of these may be directly in-
volved in binding, resulting in positional shifts in adjacent and
nearby residues. The other residues in subdomain 5 whose
chemical shifts change, are located in secondary structural
elements which are connected to the loop regions just men-
tioned, and these changes can be explained by induced struc-
tural adjustments in hydrogen bonding networks. Only four
residues in subdomain 3 change their chemical shifts: 23, 26,
27, and 50. The ¢rst three of these are located in helix 3b,
which is on the surface of the interdomain interface and has
been implicated in S3P binding by deuterium exchange experi-
ments [9].
3.2. Secondary structure comparison
The secondary structure prediction methods outlined by
Wishart et al. [13] and Wu«thrich et al. [14] were employed
for the liganded N-terminal domain. Both methods predict
that the isolated domain retains its native structure. The
chemical shift index (CSI) of the N-terminal domain plus
S3P predicts most of the same structural elements, with the
exception of the C-terminal L-strand (Fig. 3). Also in the S3P-
bound state, there are several additional NOEs observed in
residues 154^160 (Fig. 4), the segment linking subdomains 4
and 5.
4. Discussion
Based on their location on the inner face of the N-terminal
domain, which comprises half of the active site, residues iden-
ti¢ed in this study that may be involved in binding are Ser23,
Arg27, Ser197, and Tyr200 (see Fig. 2B). The behavior of
Tyr200 is especially interesting: as titration with S3P pro-
ceeds, its peak visibly broadens, presumably due to chemical
exchange, and shifts by small degrees from its original posi-
tion to its S3P-bound position. This residue is mentioned in
[6,7] as one that undergoes a major conformational change
upon S3P binding. Ser23 and Arg27 have been subjected to
Fig. 3. Plots of the chemical shift index for 1HK, 13CK, and 13CL resonances of the N-terminal domain in the presence of S3P. The secondary
structure prediction of these chemical shift changes is shown and compared with the secondary structure of the N-terminal domain within the
full-length EPSP synthase as determined by X-ray crystallography [5].
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mutagenesis (unpublished results and [15]), with 10% and un-
detectable residual activity, respectively, for the alanine sub-
stitutions. Ser23 is involved in S3P binding only in the Scho«n-
brunn binary complex structure [7], while Arg27 and Ser197
are implicated in both binary complex structures. Ser197
makes one hydrogen bond to S3P in the closed structure [7],
but two in the open structure [6]. It will be important to de¢ne
the roles of these residues in the solution state structure for an
accurate understanding of S3P binding.
While the CSI and NOE graphs predict that the basic sec-
ondary structural elements of the N-terminal domain do not
change upon either isolation or S3P binding, there are some
subtle but distinct di¡erences observed between the free and
S3P-bound states. First, the CSI predicts a shortened L-strand
at residue 140 based on the chemical shifts of the S3P-bound
species. The pattern of long-range NOEs is also di¡erent in
this region: 1HN^1HK correlations are lost between Q154 and
I140 and gained between T141 and L151. Secondly, there are
¢ve additional NOEs observed for the S3P-bound species (all
medium range and of the type 1HN^1HK) in the segment 154^
160, which links subdomains 4 and 5. This means that the last
two secondary structural elements of subdomain 4 are re-
quired to undergo some structural reorganization upon bind-
ing to S3P. This is an interesting point, since the linking seg-
ment is at a maximal distance from the active site cleft.
Clearly, though the substrate binding is localized, the struc-
tural rearrangements it induces are not.
From these results, we propose a partial conformational
change in which subdomain 4 shifts with respect to subdo-
main 5 upon S3P binding. A partial conformational change
upon S3P binding is supported by the results of Stepanek [16],
who found that monoclonal antibodies could be raised against
the binary EPSPSbS3P complex, distinct from antibodies that
recognized the enzyme alone. Also, Krekel et al. [17] found
that S3P binding did not increase the dissociation constant of
a monoclonal antibody raised against EPSP synthase, imply-
ing that S3P alone did not induce a full conformational
change that disrupted the recognition of the antibody. This
contrasted with the results of their mass spectrometric analy-
sis, and could be explained by hypothesizing that S3P induced
only a partial conformational change that allowed the anti-
body access to its epitope while restricting the access of tryp-
sin to proteolytic cleavage sites. Our NMR data support this
hypothesis and serve to describe the nature of the partial
conformational change as it occurs in the N-terminal domain.
It is clear from the ternary enzymebS3PbGLP structure [7]
that residues from both domains contribute to the active site
of EPSP synthase. One remaining question regarding the for-
mation of the active site is whether or not S3P alone triggers
the shift to a closed conformation. The isolation of the do-
mains of EPSP synthase, originally designed to facilitate the
NMR assignment process, has provided a means of answering
this question by deconvolution of the contributions of the
individual domain to the events of binding and catalysis.
For instance, we showed previously that the N-terminal do-
main is the primary energetic contributor to S3P binding [9],
which suggests the possibility of an open binary complex and
lends support to the Stallings structure [6]. Furthermore, the
isolation of the N-terminal domain will eventually allow the
di¡erentiation of the e¡ects of S3P binding and domain clo-
sure from comparison of the solution state structure with the
closed binary crystal structure.
In summary, chemical shift mapping localizes S3P binding
to selected residues in subdomains 3 and 5, a limited number
of which are logical candidates for substrate binding based on
their position at the active site. Secondary chemical shift and
Fig. 4. A summary of the NOE data de¢ning the secondary structure of the N-terminal domain in the presence of S3P. For the sequential
NOEs involving HN and HK protons, the NOE intensities are indicated by the width of the bars. The bottom line of each panel shows the sec-
ondary structure predicted by CSI for comparison. Residue labels outlined in boxes are those whose chemical shifts change signi¢cantly upon
binding to S3P.
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NOE data indicate that a majority of the secondary structural
elements present in the protein fragment alone are undis-
turbed by substrate binding. Exceptions to this ¢nding suggest
a relative conformational shift of subdomains 4 and 5 upon
S3P binding. Our results agree well with, and help to explain,
previous biochemical and structural studies. They will provide
the basis for further NMR studies on the structural and func-
tional properties of EPSP synthase.
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